Journal
NEURON
Volume 95, Issue 2, Pages 326-+Publisher
CELL PRESS
DOI: 10.1016/j.neuron.2017.06.018
Keywords
-
Categories
Funding
- NIH [NS32196, GM54728, NS55251]
- Simons Foundation [SF273555]
- ARC [DP160100849]
- NHMRC [APP1122351]
- Autism Science Foundation [REG 15-006]
Ask authors/readers for more resources
The synaptic adhesion molecules Neurexin and Neuroligin alter the development and function of synapses and are linked to autism in humans. In C. elegans, post-synaptic Neurexin (NRX-1) and pre-synaptic Neuroligin (NLG-1) mediate a retrograde synaptic signal that inhibits acetylcholine (ACh) release at neuromuscular junctions. Here, we show that the retrograde signal decreases ACh release by inhibiting the function of pre-synaptic UNC-2/CaV2 calcium channels. Post-synaptic NRX-1 binds to an auxiliary subunit of pre-synaptic UNC-2/CaV2 channels (UNC-36/alpha 2 delta), decreasing UNC-36 abundance at pre-synaptic elements. Retrograde inhibition is mediated by a soluble form of NRX-1's ectodomain, which is released from the post-synaptic membrane by the SUP-17/ADAM10 protease. Mammalian Neurexin-1 alpha binds alpha 2 delta-3 and decreases CaV2.2 current in transfected cells, whereas Neurexin-1 alpha has no effect on CaV2.2 reconstituted with alpha 2 delta-1 and alpha 2 delta-2. Collectively, these results suggest that alpha-Neurexin binding to alpha 2 delta is a conserved mechanism for regulating synaptic transmission.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available